Strains of Escherichia coli K-12 that cannot form D-serine deaminase do not grow in the presence of D-serine. Mutants unable to form the enzyme can be isolated by standard screening procedures (2) . We wished to determine whether regulatory mutants of the lac ia (5) type can occur in the D-serine deaminase system. Thus, we treated dsdA+ dsdC+/F'dsdA+ dsdC+ and dsdA+ dsdCx3/F'dsdA+ dsdCx3 homozygotes, derived from the heterozygous strain EM 20031 (4), with exposure to nitrosoguanidine (1) followed by penicillin selection, and isolated more than 200 apparently D-serine-sensitive mutants from each. However, all of the mutants derived from the inducible homozygote could be induced to form enzyme upon exposure to suboptimal levels of D-serine (50 ,ug/ml as compared to 500 jug/ml used in penicillin screening), and all of the constitutive homozygotes formed the normal complement of enzyme. Clearly, the sensitivity was not to D-serine.
Commercial D-serine (Nutritional Iliochemicals Corp.) is contaminated with 3 to 5% L-serine (Cosloy, unpublished data). Several of the mutants were streaked on minimal medium (2) supplemented with 25 jug of L-serine per ml or 500 ,ug of D-serine per ml. They failed to grow on these media but grew well on unsupplemented minimal plates, indicating that the true defect is abnormal sensitivity to L-serine. We suggest the designation Iss (L-serine-sensitive) for such mutations.
In some cases, D-serine enhanced the L-serine effect, presumably because of its own toxic effect. Two of the lss mutants, EM 20033 and EM 20034, together with a similar mutant, EM 20035, isolated from the haploid strain EM 1100 (3), were selected for further study.
The response of the Iss mutants to various conditions of growth on solid media is presented in Table 1 . There are some differences among them. EM 20035 is more sensitive to L-serine than the others; L-threonine at concentration 50 ,ug/ml is less effective in reversing the inhibition in EM 20033 than in the others. However, it is clear that compounds of the threonine-isoleucine pathway can completely overcome the L-serine effect.
It seemed of interest to determine whether mutations at more than one locus could evoke the Iss phenotype. Three of the mutations were mapped approximately by standard mating procedures (3), and the mutation of strain EM 20033 was also mapped by P1 transduction (2). All three proved to be at different loci. The lss locus of strain EM 20033 is 30 to 40% cotransduced with lac. The Iss locus of strain EM 20034 is transferred at 47 min by Hfrl (proximal marker lac, ccw transfer), about the time at which this Hfr transfers markers in the ilv region. The Iss locus of strain EM 20035 is transferred at 5 to 10 min by Hfr6 (terminal marker lac, cw transfer), about the same time that this Hfr transfers try. The data suggest that the first mutation is in one of the ilv genes, but it is not obvious what the others may be. It is possible that if more of the mutations had been mapped, more Iss loci would have been found.
The Iss mutations do not seem to be unusually common. No attempt was made in the mutant selections to score for mutations at unrelated loci, but the frequency at which lss mutations appeared in four independent mutations and selection experiments which we performed was less than that at which his and dsdA mutations appeared in analogous experiments performed with the same mutagen in the same period. Thus, either the total number of loci at which such mutations may occur is fairly limited, or the probability of such a mutation occurring at most Iss loci is fairly low. Refers to the time of incubation at 37 C. b Abbreviations: ile, isoleucine; ilv, isoleucine-valine; leu, leucine; met, methionine; pan, panothenate; ser, serine; thr, threonine.
c All growth is recorded on a relative basis, with +4 indicating the amount of growth found on minimal media with no additions.
